Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses
ConditionPeritoneal Carcinomatosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorUniversity of Regensburg
About this trial
Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses
Eligibility criteria
Qualifiers
suspicious peritoneal carcinomatosis
Disqualifiers
<18 years
Trial design
Treatments tested in this trial
- Not listed
Trial groups
250 Participants
are grouped into 2 trial groupsSponsors and collaborators
University of Regensburg
Lead sponsor
Krankenhaus Barmherzige Brüder, Regensburg
Collaborator
Source ClinicalTrials.gov